Tag Archives: Dimebon

Not With A Bang

And so we bid a not-so-fond farewell to Dimebon. It is not as if anyone–anyone?–expected the last Pfizer/Medivation clinical study for Dimebon, this one in conjunction with Aricept, to provide anything more than a postscript. Still, the announcement of that … Continue reading

Posted in Big Pharma | Tagged , , , , | 2 Comments